The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

Children’s Health Defense, founded by the health secretary, had published online a vaccine-safety page that looked like the ...

Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial ...

Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ Platform TM provides ...

Retro Biosciences is trying to help us live longer—and healthier. Here's everything you need to know about this innovative company.